Birchview Capital’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Birchview Capital’s Portfolio SILK Stock Details SILK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-158,094	Closed	-$4.27M	–	64
2024 Q2	$4.27M	Hold	158,094	–	–	3.95%	5
2024 Q1	$2.9M	Hold	158,094	–	–	2.36%	9
2023 Q4	$1.94M	Buy	158,094 +116,800	+283%	+$1.1M	1.52%	14
2023 Q3	$619K	Buy	41,294 +21,294	+106%	+$443K	0.53%	32
2023 Q2	$650K	Buy	20,000 +10,000	+100%	+$365K	0.49%	32
2023 Q1	$391K	Hold	10,000	–	–	0.31%	35
2022 Q4	$529K	Hold	10,000	–	–	0.37%	33
2022 Q3	$450K	Hold	10,000	–	–	0.32%	39
2022 Q2	$364K	Hold	10,000	–	–	0.26%	44
2022 Q1	$413K	Buy	10,000 +2,000	+25%	+$70.4K	0.3%	43
2021 Q4	$341K	Buy	+8,000	New	+$400K	0.22%	53

Other funds holding SILK

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Birchview Capital's SILK Position: Q3 2024 in Review

Birchview Capital sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q3 2024, closing a stake of 158,094 shares — an estimated $4.27M sold.

Birchview Capital first reported a position in SILK in Q4 2021 and held it in 11 quarters. The position peaked at $4.27M in Q2 2024. 1 fund tracked by Wall St. Rank holds SILK as of Q3 2024.

Birchview Capital reported no remaining Silk Road Medical, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Birchview Capital sold 158,094 Silk Road Medical, Inc. Common Stock shares in Q3 2024, an estimated $4.27M.
Birchview Capital first reported a position in Silk Road Medical, Inc. Common Stock in Q4 2021 and held it in 11 quarters.
Birchview Capital's Silk Road Medical, Inc. Common Stock position peaked at $4.27M in Q2 2024.
1 fund tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q3 2024.

Based on Birchview Capital's 13F filing for Q3 2024, filed 14 Nov 2024.